Healthequity (HQY) Share-based Compensation (2013 - 2026)

Healthequity's Share-based Compensation history runs 14 years deep, the most recent figure standing at $19.4 million for Q2 2026.

• On a quarterly basis, Share-based Compensation rose 35.37% year-over-year to $19.4 million in Q2 2026; TTM through Apr 2026 was $78.1 million, a 0.77% decrease from a year earlier, with the FY2026 full-year figure at $73.1 million, down 24.23% from the prior year.
• Share-based Compensation rose to $19.4 million in Q2 2026 per HQY's latest filing, from $19.1 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $32.0 million in Q2 2024 and bottomed at $11.0 million in Q1 2022.
• The 5-year median for Share-based Compensation is $19.1 million (2025), against an average of $18.9 million.
• Across the five-year window, Share-based Compensation soared 75.9% in 2024 and sank 55.23% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $18.2 million in 2022, then gained by 19.22% to $21.7 million in 2023, then fell by 2.49% to $21.1 million in 2024, then fell by 2.75% to $20.5 million in 2025, then slipped by 5.53% to $19.4 million in 2026.
• Per Business Quant, the three latest HQY Share-based Compensation figures stand at $19.4 million (Q2 2026), $19.1 million (Q1 2026), and $20.5 million (Q4 2025).